News from WCM

The event, sponsored by the institution’s BioVenture eLab, is the culmination of a nine-week mentoring program that is designed to improve the ability of Weill Cornell Medicine clinicians and researchers to commercialize their concepts.

For Ngozi Monu, the key to success is balance. By the time she entered medical school, she was a two-time Olympian with a doctorate.

An athlete, artist, writer and scientist, Claire Oh allowed her disparate passions to guide her career.

A seminar challenges stereotypes about treating geriatric patients.

A new technique developed by Weill Cornell Medicine investigators that creates an unusually stable form of RNA may illuminate many cellular processes and enable new kinds of gene therapies.

The use of cardiac magnetic resonance imaging (MRI) may improve treatment and result in more accurate diagnoses for patients who experience a type of heart attack caused by a severely narrowed artery, called an NSTEMI, finds a new study from NewYork-Presbyterian and Weill Cornell Medicine investigators.

While heart attacks that cause classic symptoms such as pressure and pain in the chest are an established risk factor for stroke because they can lead to blood clot formation, new research by Weill Cornell Medicine and NewYork-Presbyterian investigators indicates that heart attacks that have few, if any, recognized symptoms may also increase risk.

The addition of an oral immunomodulatory drug to a commonly employed antibody therapy is more effective against chronic, indolent lymphoma than the antibody alone, according to the results of a Phase 3 clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

The chemical element selenium, an essential nutrient for humans and other animals, protects the brain after a stroke and may be a basis for future stroke therapies, according to a study from scientists at Burke Neurological Institute and Weill Cornell Medicine.

Comic actor Seth Rogen and his wife are open about how Alzheimer’s disease has affected their family: her mother suffers from its early-onset form, and by age 60 she could no longer speak.

A powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables them to track the molecular evolution of cancers. 

Weill Cornell Medicine-Qatar added 49 new doctors—12 of whom are Qatari—to the medical profession during commencement on May 8.

How a patient and her doctor used precision medicine to fight her deadly uterine cancer.

A gene that originally evolved to help vertebrates’ early ancestors respond to stress is co-opted by cancers to help them resist treatment, according to a study by Weill Cornell Medicine investigators.

Trained in TB research, Pakistani native Dr. Omar Vandal, Ph.D. ’07, now oversees Gates Foundation grants that save lives worldwide.

A molecule that helps prevent fat accumulation in mammals is produced within fat tissues by stem-like cells that may be therapeutic targets for obesity and related disorders.

The work of global oncologists – whose insights and innovations reduce the burden of cancer around the world – has demonstrated value that academic medical leadership should consider when assessing these physicians for professional advancement, according to a commentary by Weill Cornell Medicine investigators.

After decades in pharmaceutical research, Dr. Bruce Reidenberg ’81, MD ’85, has found great satisfaction treating the developmentally disabled.

Weill Cornell Medicine honored 17 faculty, trainees, students and staff April 22 for their outstanding service and leadership in promoting diversity at the academic medical institution.

Weill Cornell Medicine has experienced dynamic growth in its research enterprise over the past five years, an achievement that underscores the institution’s mission to provide patients with the most advanced treatments and therapies.